
TY  - JOUR
TI  - Immunology
JO  - Allergy
VL  - 55
IS  - s63
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2000.tb04530.x
DO  - doi:10.1111/j.1398-9995.2000.tb04530.x
SP  - 72
EP  - 105
PY  - 2000
ER  - 

TY  - JOUR
AU  - Nau, Roland
AU  - Eiffert, Helmut
TI  - Minimizing the release of proinflammatory and toxic bacterial products within the host: A promising approach to improve outcome in life-threatening infections
JO  - FEMS Immunology & Medical Microbiology
VL  - 44
IS  - 1
SN  - 0928-8244
UR  - https://doi.org/10.1016/j.femsim.2005.01.001
DO  - doi:10.1016/j.femsim.2005.01.001
SP  - 1
EP  - 16
KW  - Antibiotics
KW  - Endotoxin
KW  - Peptidoglycans
KW  - Lipoteichoic acids
KW  - Bacterial DNA
KW  - Toll-like receptors
PY  - 2005
AB  - Abstract Various bacterial components (e.g., endotoxin, teichoic and lipoteichoic acids, peptidoglycans, DNA) induce or enhance inflammation by stimulating the innate immune system and/or are directly toxic in eukariotic cells (e.g., hemolysins). When antibiotics which inhibit bacterial protein synthesis kill bacteria, smaller quantities of proinflammatory or toxic compounds are released in vitro and in vivo than during killing of bacteria by ?-lactams and other cell-wall active drugs. In general, high antibiotic concentrations liberate lower quantities of bacterial proinflammatory or toxic compounds than concentrations close to the minimum inhibitory concentration. In animal models of Escherichia coli Pseudomonas aeruginosa and Staphylococcus aureus peritonitis/sepsis and of Streptococcus pneumoniae meningitis, a lower release of proinflammatory bacterial compounds was associated with a reduced mortality or neuronal injury. Pre-treatment with a bacterial protein synthesis inhibitor reduced the strong release of bacterial products usually observed during treatment with a ?-lactam antibiotic. Data available strongly encourage clinical trials comparing antibiotic regimens with different release of proinflammatory/toxic bacterial products. The benefit of the approach to reduce the liberation of bacterial products should be greatest in patients with a high bacterial load.
ER  - 

TY  - JOUR
AU  - Bjørklund, Geir
AU  - Dadar, Maryam
AU  - Martins, Natália
AU  - Chirumbolo, Salvatore
AU  - Goh, Bey Hing
AU  - Smetanina, Kateryna
AU  - Lysiuk, Roman
TI  - Brief Challenges on Medicinal Plants: An Eye-Opening Look at Ageing-Related Disorders
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 122
IS  - 6
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.12972
DO  - doi:10.1111/bcpt.12972
SP  - 539
EP  - 558
PY  - 2018
AB  - Abstract Several studies have reported that nature-derived antioxidants may prevent free radicals over-production and therefore control the onset and prevent the exacerbation of different kinds of diseases caused by oxidative stress and redox-derived stressors, including ageing, fundamentally by suppressing the oxidative by-products-mediated degradation. Naturally derived antioxidants exert their anti-ageing action via a panoply of signalling systems, many of which engaging reactive oxygen and nitrogen species scavenging, with the Nrf2/Keap1-ARE system and improving the many survival genes and functions (such as the pathway mTOR/Foxo/SIRT1) able to slow cellular senescence. Most of the research in this field has evaluated the regulative effects and even pathways of herbal extracts with antioxidant property in the ageing process, and various age-related disorders such as cardiovascular disease, ischaemia-reperfusion injury, coronary and myocardial circulatory perfusion, peripheral vascular resistance, and even neurodegenerative disorders are prevented plant phytochemicals often via their antioxidant potential. A much more complex ability to interact with survival functions makes these compounds successfully active in preventing ageing-related disorders. This report aimed to discuss in more detail some selected medicinal plants including Allium sativum, Aloe vera, Crataegus spp., Cynara scolymus, Eleutherococcus senticosus, Ginkgo biloba, Hippophae rhamnoides, Panax ginseng, Rosmarinus officinalis, Schizandra chinensis, Vitis vinifera and seaweeds in the prevention of ageing-related pathologies. A systematic overview of the relevant information in the antioxidant function of the many herbal products reviewed here for the control of the ageing process is proposed, to provide a new horizon on the design of anti-ageing herbal medicines.
ER  - 

TY  - JOUR
TI  - ORALS
JO  - Journal of Clinical Periodontology
VL  - 33
IS  - s7
SN  - 0303-6979
UR  - https://doi.org/10.1111/j.1600-051X.2006.00939.x
DO  - doi:10.1111/j.1600-051X.2006.00939.x
SP  - 23
EP  - 188
PY  - 2006
ER  - 

TY  - JOUR
TI  - Posters: Complications
JO  - Obesity Reviews
VL  - 7
IS  - s2
SN  - 1467-7881
UR  - https://doi.org/10.1111/j.1467-7881.2006.00283_4.x
DO  - doi:10.1111/j.1467-7881.2006.00283_4.x
SP  - 177
EP  - 220
PY  - 2006
ER  - 

TY  - JOUR
TI  - POSTER PRESENTATIONS
JO  - Journal of the American Geriatrics Society
JA  - Journal of the American Geriatrics Society
VL  - 44
IS  - 9
SN  - 0002-8614
UR  - https://doi.org/10.1111/j.1532-5415.1996.tb02966.x
DO  - doi:10.1111/j.1532-5415.1996.tb02966.x
SP  - S11
EP  - S86
PY  - 1996
ER  - 

TY  - JOUR
TI  - Abstracts from the International Symposium on Frontiers in Life Sciences: Molecular Basis of Disease, Prevention and Treatment
JO  - Cell Biology International
VL  - 30
IS  - 8
SN  - 1065-6995
UR  - https://doi.org/10.1016/j.cellbi.2006.07.001
DO  - doi:10.1016/j.cellbi.2006.07.001
SP  - S1
EP  - S47
PY  - 2006
ER  - 

TY  - JOUR
TI  - ABSTRACTS – Online Panel Discussion (i-Pos)
JO  - International Journal of Rheumatic Diseases
VL  - 11
IS  - s1
SN  - 1756-1841
UR  - https://doi.org/10.1111/j.1479-8077.2008.00373.x
DO  - doi:10.1111/j.1479-8077.2008.00373.x
SP  - A84
EP  - A514
PY  - 2008
ER  - 

AU  - Selgrade, Maryjane K.
AU  - Germolec, Dori R.
AU  - Luebke, Robert W.
AU  - Smialowicz, Ralph J.
AU  - Ward, Marsha D.
AU  - Bowman, Christal C.
C7  - pp. 765-803
TI  - Immunotoxicity
SN  - 9780470102114
UR  - https://doi.org/10.1002/9780470285251.ch32
DO  - doi:10.1002/9780470285251.ch32
SP  - 765-803
KW  - immunotoxicity and immunotoxicology
KW  - immune suppression mechanisms
KW  - hypersensitivity mechanisms
PY  - 2008
AB  - Summary This chapter contains sections titled: Introduction Organization of the Immune System Immunotoxicology Mechanisms of Immune Suppression Mechanisms Associated with Hypersensitivity Mechanisms Associated with Autoimmune Disease Suggested Reading
ER  - 

TY  - JOUR
TI  - ADF Abstracts 2014
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 23
IS  - 3
SN  - 9780470102114
UR  - https://doi.org/10.1111/exd.12314
DO  - doi:10.1111/exd.12314
SP  - e1
EP  - e60
PY  - 2014
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
VL  - 41
IS  - s1
SN  - 9780470102114
UR  - https://doi.org/10.1111/j.1365-2362.2011.02508.x
DO  - doi:10.1111/j.1365-2362.2011.02508.x
SP  - 23
EP  - 86
PY  - 2011
ER  - 

TI  - Haemosiderin to Hormone-Sensitive Lipase: Iduronate-2-Sulphatase to Interleukin-1 Receptor Antagonist
SN  - 9783527300938
UR  - https://doi.org/10.1002/9783527619764.ch8
DO  - doi:10.1002/9783527619764.ch8
KW  - iron storage protein
KW  - lysosomes
KW  - ferrioxyhydrite
KW  - mineralisation
KW  - haemochromatosis
PY  - 2011
ER  - 

TY  - JOUR
TI  - The 2nd Australasian Wound and Tissue Repair Society (AWTRS) Meeting
JO  - Wound Repair and Regeneration
VL  - 18
IS  - 4
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1524-475X.2010.00600.x
DO  - doi:10.1111/j.1524-475X.2010.00600.x
SP  - A59
EP  - A76
PY  - 2010
ER  - 

TY  - JOUR
TI  - ACCP Annual Meeting  Scientific Abstracts
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 36
IS  - 12
SN  - 9783527300938
UR  - https://doi.org/10.1002/phar.1877
DO  - doi:10.1002/phar.1877
SP  - e206
EP  - e344
PY  - 2016
ER  - 

TY  - JOUR
AU  - Levi, Marcel
TI  - Current understanding of disseminated intravascular coagulation
JO  - British Journal of Haematology
VL  - 124
IS  - 5
SN  - 9783527300938
UR  - https://doi.org/10.1046/j.1365-2141.2003.04790.x
DO  - doi:10.1046/j.1365-2141.2003.04790.x
SP  - 567
EP  - 576
KW  - disseminated intravascular coagulation
KW  - tissue factor
KW  - cytokines
KW  - inflammation
KW  - protein C
PY  - 2004
ER  - 

TY  - JOUR
TI  - ASBMR 22nd annual meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 15
IS  - S1
SN  - 9783527300938
UR  - https://doi.org/10.1002/jbmr.5650150102
DO  - doi:10.1002/jbmr.5650150102
SP  - S1
EP  - S584
PY  - 2000
ER  - 

TY  - JOUR
TI  - Oral Presentation (As Appear in the Program)
JO  - American Journal of Reproductive Immunology
JA  - Am J Reprod Immunol
VL  - 78
IS  - S1
SN  - 9783527300938
UR  - https://doi.org/10.1111/aji.12736
DO  - doi:10.1111/aji.12736
SP  - 35
EP  - 44
PY  - 2017
ER  - 

TY  - JOUR
AU  - Conrad, Bernard
AU  - Trucco, Massimo
TI  - Superantigens as etiopathogenetic factors in the development of insulin-dependent diabetes mellitus
JO  - Diabetes/Metabolism Reviews
JA  - Diabetes Metab. Rev.
VL  - 10
IS  - 4
SN  - 9783527300938
UR  - https://doi.org/10.1002/dmr.5610100402
DO  - doi:10.1002/dmr.5610100402
SP  - 309
EP  - 338
PY  - 1994
ER  - 

TY  - JOUR
AU  - Fernández-Alfonso, M S
AU  - Gil-Ortega, M
AU  - Aranguez, I
AU  - Souza, D
AU  - Dreifaldt, M
AU  - Somoza, B
AU  - Dashwood, M R
C8  - 2016-BJP-1026-RPT-G.R1
TI  - Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?
JO  - British Journal of Pharmacology
JA  - British Journal of Pharmacology
VL  - 174
IS  - 20
SN  - 9783527300938
UR  - https://doi.org/10.1111/bph.13734
DO  - doi:10.1111/bph.13734
SP  - 3561
EP  - 3572
PY  - 2017
AB  - Perivascular adipose tissue (PVAT) releases numerous factors and adipokines with paracrine effects on both vascular structure and function. These effects are variable as they depend on regional differences in PVAT among blood vessels and vary with changes in adiposity. There is considerable evidence demonstrating an association between coronary PVAT and the development and progression of coronary artery disease, which is associated with inflammation, oxidative stress, angiogenesis, vascular remodelling and blood clotting. However, PVAT also has a protective role in vascular grafts, especially the no-touch saphenous vein, in patients undergoing coronary artery bypass. This beneficial influence of PVAT involves factors such as adipocyte-derived relaxing factor, nitric oxide (NO), leptin, adiponectin, prostanoids, hydrogen sulphide and neurotransmitters, as well as mechanical protection. This article aims to highlight and compare the dual role of PVAT in the development and progression of coronary atherosclerosis, as well as in increased graft patency. Different deleterious and protective mechanisms of PVAT are also discussed and the inside-outside signalling paradigm of atherosclerosis development re-evaluated. The bidirectional communication between the arterial and venous wall and their surrounding PVAT, where signals originating from the vascular wall or lumen can affect PVAT phenotype, has been shown to be very complex. Moreover, signals from PVAT also influence the structure and function of the vascular wall in a paracrine manner. Linked Articles This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue ? Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc
ER  - 

TY  - JOUR
AU  - Lipton, Stuart
TI  - Plenary Talk P04: Paradigm shift in neuroprotective drug treatment
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9783527300938
UR  - https://doi.org/10.1111/j.1474-1644.2005.03231_1.x
DO  - doi:10.1111/j.1474-1644.2005.03231_1.x
SP  - 113
EP  - 113
PY  - 2005
ER  - 
